Studies on the relationships between sensitivity to cold, dry air, hyperosmolal solutions, and histamine in the adult nose

The American Review of Respiratory Disease
A G TogiasR M Naclerio

Abstract

We have previously reported that elevated osmolality of nasal secretions is linked to the rhinitic reaction to cold and dry air (CDA) that results in inflammatory mediator release and that nasal challenge with hyperosmolal solutions can induce histamine release in randomly selected individuals. These findings led to a comparison of the effect of nasal challenge with hypertonic fluid in 11 subjects who demonstrated a nasal response to CDA compared to 10 subjects without CDA sensitivity. All volunteers were challenged with isosmolal (300 mosmol/kg H2O) and hyperosmolal (800 mosmol/kg H2O) mannitol solutions. Their response was evaluated by symptom scores and quantification of histamine in nasal lavages. CDA responders differed significantly from non-responders in terms of both the total amount and the concentration of histamine in the lavage following hyperosmolal challenge (p less than 0.04 and p less than 0.02, respectively). In addition, CDA responders reported a higher change from baseline for nasal congestion, pruritus, and lacrimation following hyperosmolal challenge, but the scores for rhinorrhea, the volume of the returned nasal lavage fluid following hyperosmolal challenge, and the capacity to reduce the osmolality of th...Continue Reading

References

May 1, 1976·The Annals of Otology, Rhinology, and Laryngology·W R Wilson, M R Allansmith
Oct 1, 1985·The Journal of Clinical Investigation·A G TogiasL M Lichtenstein
May 1, 1986·The Journal of Allergy and Clinical Immunology·C M Smith, S D Anderson

❮ Previous
Next ❯

Citations

Mar 15, 2002·Current Allergy and Asthma Reports·S E SobolQ A Hamid
Mar 29, 2002·Current Allergy and Asthma Reports·Wytske J Fokkens
Apr 18, 2008·Current Allergy and Asthma Reports·Alvaro A Cruz, Alkis Togias
Sep 3, 2013·Experimental Eye Research·Ian D Meng, Masayuki Kurose
Apr 26, 2002·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·J N BaraniukK Naranch
Aug 12, 1999·Allergy
Aug 3, 1999·American Journal of Respiratory and Critical Care Medicine·J N BaraniukK Naranch
Sep 16, 2000·American Journal of Respiratory and Critical Care Medicine·P AssanasenR M Naclerio
Dec 1, 1993·The American Review of Respiratory Disease·G PhilipA G Togias
Oct 13, 2004·American Journal of Respiratory and Critical Care Medicine·James N BaraniukBenjamin Nelson
Oct 7, 2006·American Journal of Respiratory and Critical Care Medicine·Frank D GillilandDavid Diaz-Sanchez
Jan 1, 1995·European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·G Philip, A G Togias
Jul 9, 2011·Immunology and Allergy Clinics of North America·Michael A Kaliner
Sep 8, 2004·Respiratory Physiology & Neurobiology·Silke HeindlChristoph Dodt
Jun 6, 2006·The Journal of Allergy and Clinical Immunology·Alvaro A CruzAlkis Togias
Jan 6, 2006·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·L S HanesA Togias
Jan 19, 2008·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·R J SalibP H Howarth
Aug 9, 2011·American Journal of Rhinology & Allergy·Peter K Smith, Joel Collins
Nov 4, 2005·Allergy·J B van RijswijkW J Fokkens

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.